
PhosTAC7
CAS No. 3016307-75-5
PhosTAC7( —— )
Catalog No. M37132 CAS No. 3016307-75-5
PhosTAC7 successfully induced ternary protein complex formation and dephosphorylation of phosphatidylserine 318 (pS318) by Halo-FOXO3a in a dose-dependent manner.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 439 | Get Quote |
![]() ![]() |
5MG | 655 | Get Quote |
![]() ![]() |
10MG | 1121 | Get Quote |
![]() ![]() |
25MG | 2134 | Get Quote |
![]() ![]() |
50MG | 3432 | Get Quote |
![]() ![]() |
100MG | 4437 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePhosTAC7
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhosTAC7 successfully induced ternary protein complex formation and dephosphorylation of phosphatidylserine 318 (pS318) by Halo-FOXO3a in a dose-dependent manner.
-
DescriptionPhosTAC7 successfully induced ternary protein complex formation and dephosphorylation of phosphatidylserine 318 (pS318) by Halo-FOXO3a in a dose-dependent manner.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3016307-75-5
-
Formula Weight1119.77
-
Molecular FormulaC58H87ClN2O17
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H](C(=O)N1[C@H](C(O[C@H](CCC2=CC(OC)=C(OC)C=C2)C3=CC(OCC(NCCOCCOCCOCCOCCOCCOCCOCCCCCCCl)=O)=CC=C3)=O)CCCC1)(CC)C4=CC(OC)=C(OC)C(OC)=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
3-Phosphoglyceric ac...
3-Phosphoglyceric acid is a metabolic intermediate in glycolysis and the Calvin cycle, and it is also involved in alveolar macrophage epigenetic regulation.
-
GSK-626616
GSK-626616 is a potent and orally bioavailable DYRK3 inhibitor (IC50: 0.7 nM). It inhibits other members of the DYRK family with similar potency. GSK-626616 is a potential therapy for the treatment of anemia.
-
LDN-212320
LDN-212320 is a glutamate transporter EAAT2 activator. It also enhances EAAT2 levels by > 6 fold at concentrations < 5 μM after 24 h.